An aphasic syndrome in children

The paper presents case reports of nine children, all of whom had severe disturbances of language function of abrupt or gradual onset. Seizures occurred in seven of the children and all nine had EEG abnormalities.There was no apparent correlation between the seizures, the EEG changes and the aphasia. One patient had a brain biopsy performed at another hospital and the tissue was said to be normal. The cause of the abnormal language function is unknown. Five of the children failed to acquire normal speech subsequently. Three of the four children who made a complete recovery were treated with steroids.     

Location of phosphorylase kinase (Phk) in the mouse X chromosome

The phosphorylase kinase deficiency (Phk) locus has been located in the mouse X chromosome, the order of genes being centromere-Bn-Phk-Ta-jp. Since the Phk locus of the mouse may be identical to the locus responsible for the X-linked phosphorylase kinase deficiency trait of man, and there may be a high degree of gene-order homology in the X chromosome of all mammals, the location of Phk in the mouse reported here may aid in locating the phosphorylase kinase gene on the X chromosome of man.This research was supported by grants AM 13359 (to F.H.) and AM 14461 (to D.L.C.) from the National Institute of Arthritis and Metabolic Diseases, and by an allocation (to E.M.E.) from NIH General Research Support Grant RR-05545 from the Division of Research Resources to The Jackson Laboratory. F.H. is a recipient of a Research Career Development Award (AM 46 421) of the National Institute of Arthritis and Metabolic Diseases.     

In Vitro Susceptibility of Neisseria gonorrhoeae to Nine Antimicrobial Agents

The in vitro action of nine antibiotics was tested by the agar streak method against 45 gonococcal strains isolated from penicillin-therapy failures. The penicillin susceptibility range of these strains was 0.003 to 1.32 μg/ml, and the tetracycline susceptibility range was 0.125 to 2.0 μg/ml. Minimal inhibitory concentrations of minocycline and doxycycline paralleled the activity of tetracycline and ranged from 0.125 to 1.0 μg/ml and 0.125 to 2.0 μg/ml, respectively. Rifampicin, with a narrow range of 0.5 to 1.0 μg/ml, inhibited 75% of the strains at 0.5 μg/ml. The range for cephaloridine and cephaloglycine was 0.5 to 20.0 μg/ml, but another cephalosporium derivative, cephalexin, exhibited greater activity in its range of 0.25 to 20.0 μg/ml. A semisynthetic penicillin, carbenicillin, with a range of 0.025 to 0.75 μg/ml, displayed more activity against the lower susceptible penicillin G gonococcal strains.     

Xylene Poisoning: A Report on One Fatal Case and Two Cases of Recovery after Prolonged Unconsciousness

Three cases of xylene poisoning occurred after prolonged inhalation of paint fumes. Analysis showed that xylene comprised more than 90% of the solvent in the paint, the total solvent comprising 34% of the paint by weight. One patient was dead on admission, while the other two recovered after at least 15 hours'' loss of consciousness. Both patients had transient liver cell damage, and one temporary impairment of renal function.     

Effect of RA233 on Platelet Function In Vitro

RA233, a new pyrimido-pyrimidine compound, is a powerful inhibitor of platelet function tested in vitro; it inhibits calcium and adenosine diphosphate (A.D.P.)-induced platelet aggregation, inhibits the retention of platelets by glass beads, decreases the release of platelet factor 3 by kaolin, and inhibits clot retraction. In some in-vitro systems RA233 is significantly more potent that its analogue RA433 in inhibiting platelet function.     

Space biomagnetics

Astronauts who venture from their spacecraft onto the lunar surface and the surfaces of our neighboring planets will be exposed for a few hours in duration to magnetic-field intensities which are markedly less than that of the earth's field. The intensities of magnetic fields to which they will be exposed while inside their spacecraft can be stated only after completing a detailed survey of the contribution made to these fields by the functioning electronic components of spacecraft. Assessment of individuals regularly working in and exposed continuously for 10 days to magnetic fields less than 100 gammas in intensity indicate that extremely low-intensity magnetic fields encountered during a nominal Apollo moon mission should not affect astronaut health or performance. Careful physiological and psychological observations first on higher primates, then on man exposed to such fields for more prolonged periods of time must be carried out before this conclusion can be drawn for longer exposures.Recent technological advances in propulsion and radiation protection have made it possible that astronauts might also be exposed intermittently to high-intensity, relatively low-gradient magnetic fields during space missions. The duration of such exposures could range from less than an hour if an activated magnetohydrodynamic engine must be serviced, to several days if pure magnetic or plasma-radiation shielding is used for astronaut protection from solar flare radiation. From past experience with personnel who enter high-intensity magnetic fields for brief periods of time in their work, magnetic-field exposures while servicing magnetohydrodynamic engines should not be hazardous to astronauts. On the other hand, past exposures of man and sub-human systems to high-intensity magnetic fields do not indicate whether or not astronauts who are exposed for up to several days to currently estimated magnetic-field intensities associated with pure magnetic or plasma-radiation shielding could suffer impairment of their health or performance. This answer can be obtained only by carefully conducted experiments which closely simulate such exposures, and look closely for physiological, psychological and pathological changes, especially in exposed higher primates, before assessing the response of man to such exposures.Magnetic force is animate or imitates life; and in many things surpasses human life, while this is bound up in the organick body.Prepared under Contract NASr-115 at The Lovelace Foundation for Medical Education and Research, Albuquerque, N.M., U.S.A.